Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,295 | 20,830 | 16,523 | 20,657 | 0 |
| Receivables | 4,984 | 4,057 | 4,514 | 4,001 | 0 |
| Inventories | 3,022 | 1,406 | 1,069 | 2,615 | 0 |
| TOTAL | $23,932 | $28,014 | $23,025 | $28,621 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,279 | 1,537 | 1,777 | 2,049 | N/A |
| TOTAL | $1,279 | $1,537 | $1,777 | $2,049 | $N/A |
| Total Assets | $25,211 | $29,551 | $24,802 | $30,670 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,618 | 871 | 1,352 | 2,364 | 0 |
| Accrued Expenses | 2,702 | 3,629 | 2,900 | 2,815 | 0 |
| Other current liabilities | N/A | N/A | 271 | N/A | 0 |
| TOTAL | $7,541 | $4,714 | $4,523 | $5,515 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,622 | 18,376 | 9,029 | 9,008 | 0 |
| Deferred Revenues | 421 | 214 | N/A | 336 | N/A |
| Other Non-Current Liabilities | 174 | 287 | 1,113 | 767 | 0 |
| TOTAL | $19,015 | $18,968 | $10,142 | $9,920 | $N/A |
| Total Liabilities | $26,556 | $23,681 | $14,665 | $15,435 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18 | 18 | 17 | 17 | N/A |
| Common Shares | 1 | 1 | 1 | 1 | 0 |
| Retained earnings | -88,279 | -80,614 | -72,762 | -66,351 | 0 |
| TOTAL | $-1,345 | $5,870 | $10,137 | $15,235 | $0 |
| Total Liabilities And Equity | $25,211 | $29,551 | $24,803 | $30,670 | $0 |